Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Participants needed: 235
Trial details
Age: 22-75Biological sex: FemaleType: InterventionalSponsor: Tela Bio IncUpdated: Jun 2, 2026Locations: 2
Eligibility criteria

Patient is a female between the ages of 22 - 75, inclusive, at the time of enrol... [+4]

Patient has a BMI < 18.5 or > 35; [+18]

Read more
Status: Recruiting

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Participants needed: 160
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Tela Bio IncUpdated: May 5, 2026Locations: 10
Eligibility criteria

Subject suffers from a ventral or inguinal hernia that requires surgical repair... [+7]

Subject has a BMI of > 40 [+9]

Read more
Status: Recruiting

Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.

Participants needed: 173
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Tela Bio IncUpdated: Feb 9, 2026Locations: 2
Eligibility criteria

Patient is a candidate for an elective robotic or laparoscopic primary hiatal he... [+4]

Patient has a Body Mass Index (BMI) of ≥ 35. [+19]

Read more
Status: Recruiting

A Retrospective Assessment of OviTex PRS (OviTex)

The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.

Participants needed: 200
Trial details
Age: 18-75Biological sex: FemaleType: ObservationalSponsor: Tela Bio IncUpdated: Aug 15, 2025Locations: 11
Eligibility criteria

Patient was between 18 years and 75 years of age (inclusive) at the time of surg... [+2]

Patient received a textured permanent breast implant. [+2]

Read more